Paradigm Biopharmaceuticals scores A$16m investment—Here’s what it means for osteoarthritis treatment

Pallavi Madhiraju- December 9, 2024 0

Paradigm Biopharmaceuticals Ltd. (ASX: PAR) has secured a significant A$16 million in funding, positioning the company to launch its pivotal Phase 3 global clinical trial ... Read More

Zydus Lifesciences’ Diclofenac Sodium and Misoprostol Tablets gets FDA final approval

Pallavi Madhiraju- June 18, 2023 0

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to manufacture and market Diclofenac Sodium and Misoprostol Delayed Release Tablets ... Read More

Syngene signs Librela-focused biologics manufacturing agreement with Zoetis

Pallavi Madhiraju- July 17, 2022 0

Syngene International Limited has signed a 10-year biologics manufacturing agreement with American animal health company Zoetis for manufacturing the drug substance for Librela (bedinvetmab), a ... Read More

Lupin rolls out generic version of Ibuprofen and Famotidine Tablets in US

pallavi123- September 20, 2021 0

Lupin Limited said that it has rolled out the authorized generic version of Horizon Medicines’ Duexise (ibuprofen and famotidine) Tablets, 800 mg/26.6 mg. Ibuprofen and ... Read More

Ensemble Orthopedics secures FDA clearance for innovative CMC implant for osteoarthritis treatment

pharmanewsdaily- December 6, 2020 0

Ensemble Orthopedics, a Texas-based medical device company, has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its innovative Ensemble CMC Implant. ... Read More

Antibe Therapeutics completes patient enrollment in OA knee pain trial for ATB-346

pharmanewsdaily- March 2, 2020 0

Antibe Therapeutics, a Canadian pharma company has completed enrollment of patients in a phase 2B dose-ranging, efficacy clinical trial of its lead drug candidate ATB-346 ... Read More

Teva and Regeneron report positive Phase 3 results for Fasinumab in osteoarthritis pain management

pharmanewsdaily- August 19, 2018 0

Teva Pharmaceutical Industries and Regeneron Pharmaceuticals have announced successful outcomes from their phase 3 study of fasinumab, a nerve growth factor (NGF) antibody, in patients ... Read More

Fibrous foods aids arthritis treatment by relieving arthritis symptoms

pharmanewsdaily- May 1, 2018 0

As per the latest research studies, adults who eat lot of fibrous foods are at low risk of getting osteoarthritis that causes knee pain and ... Read More

Amazing Arthritis Prevention Tips & Natural Remedies for Arthritis Revealed!

pharmanewsdaily- March 30, 2018 0

Know about Arthritis – the common bone and joint problem. Find out the different types of Arthritis, Arthritis treatment and the Arthritis natural Remedies. Arthritis ... Read More

Simple tips for treating arthritis | Weight loss through balanced diet or diet alone keeps arthritis at bay

pharmanewsdaily- March 24, 2018 0

As per the recent research, it is revealed that losing weight by following a balanced diet and regular exercise can keep your knees healthy in ... Read More